Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by ADMA Biologics, Inc.

ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Second Quarter 2025 Financial Results on August 6, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces First Quarter 2025 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report First Quarter 2025 Financial Results on May 7, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces U.S. FDA Approval of Innovative Production Yield Enhancement Process
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Statement on Tariffs
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Preliminary Full Year 2024 Revenue and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Participate in the J.P. Morgan Healthcare Conference on January 13, 2025
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Partial Paydown of Senior Term Loan Credit Facility
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Third Quarter 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Third Quarter 2024 Financial Results on November 7, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Set to Join S&P SmallCap 600 Index
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Participate in the 2024 Cantor Global Healthcare Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Partial Paydown of Revolving Credit Facility
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Second Quarter 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Second Quarter 2024 Financial Results on August 8, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces First Quarter 2024 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report First Quarter 2024 Financial Results on May 9, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces FDA Approvals of Extended Room Temperature Storage Conditions for ASCENIV™ & BIVIGAM®
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Participate in the Raymond James Institutional Investor Conference
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces CFO Transition
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Successfully Implements Innovative AI Program, Named ADMAlytics
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces Preliminary Fourth Quarter 2023 Revenue and Provides Business Update
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces $135 Million Non-Dilutive Refinancing of Credit Facilities with Ares Management
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
ADMA Biologics Announces FDA Approval for BIVIGAM® in the Pediatric Patient Setting for Those 2 Years of Age and Older
From ADMA Biologics, Inc.
Via GlobeNewswire
Tickers ADMA
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.